STADA Arzneimittel AG Says Sells U.S. Unit For Around $40 Million

Published: Jul 13, 2006

FRANKFURT, July 13 (Reuters) - German generic drugmaker Stada Arzneimittel (STAGn.DE: Quote, Profile, Research) has agreed to sell its unprofitable U.S. unit to New Jersey-based DAVA Pharmaceuticals for around $40 million, it said in a statement on Thursday.

Back to news